{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:28:19Z","timestamp":1772641699746,"version":"3.50.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Laboratory immunologists occasionally encounter rare immunofluorescence patterns, such as the centromere protein F (CENP-F)\u2013like pattern, classified as AC-14 by the International Consensus on ANA Patterns (ICAP). The clinical and biological significance of anti-CENP-F antibodies remains unclear, but their presence appears to be related to events involving increased or abnormal cell proliferation, including malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case report describes the diagnostic journey of a patient who presented with clinical manifestations of chronic spontaneous urticaria (CSU), the laboratory report for which indicated the presence of a CENP-F-like (AC-14) antinuclear antibody (ANA) pattern during routine testing for the cause of her symptoms. Concerned by the result, the patient independently searched for information online and discovered a potential association between anti-CENP-F autoantibodies and cancer. This search led to considerable anxiety and prompted her to pursue further medical evaluations to rule out malignancy. The resulting diagnostic pathway involved consultations across several medical disciplines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This case highlights the complexity of interpreting uncommon ANA patterns and underscores the critical role of the laboratory in such contexts. In particular, it emphasizes that (1) ANA testing should be requested only in well-defined clinical contexts; (2) the CENP-F-like ANA pattern is not diagnostic of malignancy in low-risk patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Laboratories can play a crucial role in supporting clinicians, providing confirmation of laboratory results, even in the absence of commercial tests for determining the antigenic specificity. We believe that this case exemplifies the importance of correct and careful laboratory reporting, especially in an era where patients frequently engage in self-diagnosis. It also underlines the value of multidisciplinary collaboration in the management of unexpected laboratory results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/labmed\/lmaf092","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:34:46Z","timestamp":1765197286000},"source":"Crossref","is-referenced-by-count":0,"title":["Reporting the CENP-F-like (AC-14) antinuclear antibody pattern in the internet age: a case report"],"prefix":"10.1093","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5149-9223","authenticated-orcid":false,"given":"Sally","family":"Maramotti","sequence":"first","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Cocconcelli","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Dardani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Belloni","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8622-0439","authenticated-orcid":false,"given":"Stefania","family":"Croci","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Giovanelli","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Galli","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Zerbini","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS di Reggio Emilia , Reggio Emilia,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2026030406391774900_lmaf092-B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026030406391774900_lmaf092-B2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026030406391774900_lmaf092-B3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jalm\/jfab140","article-title":"The International Consensus on ANA Patterns in 2021\u2014the 6th workshop and current perspectives","volume":"7","author":"Chan","year":"2022","journal-title":"J Appl Lab Med"},{"key":"2026030406391774900_lmaf092-B4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"2026030406391774900_lmaf092-B5","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/art.39706","article-title":"Autoantibody-positive healthy individuals display unique immune profiles that may regulate autoimmunity","volume":"68","author":"Slight-Webb","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026030406391774900_lmaf092-B6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.autrev.2013.03.014","article-title":"Prevalence and clinical significance of rare antinuclear antibody patterns","volume":"12","author":"Vermeersch","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2026030406391774900_lmaf092-B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13317-016-0075-0","article-title":"International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results","volume":"7","author":"Damoiseaux","year":"2016","journal-title":"Auto Immun Highlights"},{"key":"2026030406391774900_lmaf092-B8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA Patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026030406391774900_lmaf092-B9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1242\/jcs.106.4.1045","article-title":"Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis","volume":"106(pt 4)","author":"Casiano","year":"1993","journal-title":"J Cell Sci"},{"key":"2026030406391774900_lmaf092-B10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-8411(95)90009-8","article-title":"Autoimmunity to the cell cycle-dependent centromere protein p330d\/CENP-F in disorders associated with cell proliferation","volume":"8","author":"Casiano","year":"1995","journal-title":"J Autoimmun"},{"key":"2026030406391774900_lmaf092-B11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.autrev.2010.09.025","article-title":"Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F","volume":"10","author":"Fritzler","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2026030406391774900_lmaf092-B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1476-4598-12-95","article-title":"Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay","volume":"12","author":"Welner","year":"2013","journal-title":"Mol Cancer"},{"key":"2026030406391774900_lmaf092-B13","first-page":"308","article-title":"High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F","volume":"20","author":"Rattner","year":"1997","journal-title":"Clin Invest Med"},{"key":"2026030406391774900_lmaf092-B14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1196\/annals.1313.034","article-title":"Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin\u2019s lymphoma","volume":"1050","author":"Bencimon","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"2026030406391774900_lmaf092-B15","doi-asserted-by":"publisher","first-page":"105885","DOI":"10.1016\/j.jbspin.2025.105885","article-title":"Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: insights from a large cohort study","volume":"92","author":"Le Joncour","year":"2025","journal-title":"Joint Bone Spine"},{"key":"2026030406391774900_lmaf092-B16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"2026030406391774900_lmaf092-B17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"2026030406391774900_lmaf092-B18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11882-013-0366-8","article-title":"Urticaria and autoimmunity: where are we now?","volume":"13","author":"Stitt","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"2026030406391774900_lmaf092-B19","doi-asserted-by":"publisher","first-page":"7468453","DOI":"10.1155\/2022\/7468453","article-title":"Do antinuclear antibodies influence the clinical features of chronic spontaneous urticaria?: A retrospective cohort study","volume":"2022","author":"Arunkajohnsak","year":"2022","journal-title":"Biomed Res Int"},{"key":"2026030406391774900_lmaf092-B20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cea.12673","article-title":"Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus\u2014a systematic review","volume":"46","author":"Kolkhir","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"2026030406391774900_lmaf092-B21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1468-3083.2011.04302.x","article-title":"IgE- mediated allergy: a rare cause of chronic spontaneous urticaria with allergen-specific immunotherapy as treatment option\u2014a systematic review with meta- analysis from China","volume":"26","author":"Shi","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026030406391774900_lmaf092-B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/antib10010009","article-title":"Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease","volume":"10","author":"Pashnina","year":"2021","journal-title":"Antibodies"},{"key":"2026030406391774900_lmaf092-B23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2015.12.002","article-title":"Choosing wisely: review and commentary on anti-nuclear antibody (ANA) testing","volume":"15","author":"Fritzler","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2026030406391774900_lmaf092-B24","doi-asserted-by":"publisher","first-page":"103608","DOI":"10.1016\/j.autrev.2024.103608","article-title":"Reflecting on a decade of the International Consensus on ANA Patterns (ICAP): accomplishments and challenges from the perspective of the 7th ICAP workshop","volume":"23","author":"Andrade","year":"2024","journal-title":"Autoimmun Rev"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/2\/lmaf092\/66815308\/lmaf092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/2\/lmaf092\/66815308\/lmaf092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:39:25Z","timestamp":1772624365000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/doi\/10.1093\/labmed\/lmaf092\/8468459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmaf092","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,9]]},"article-number":"lmaf092"}}